Dentsply Sirona (XRAY) Tops Q2 EPS by 6c, Offers FY Guidance

Dentsply Sirona (NASDAQ: XRAY) reported Q2 EPS of $0.71, $0.06 better than the analyst estimate of $0.65. Revenue for the quarter came in at $1.07 billion versus the consensus estimate of $1.01 billion.

GUIDANCE:

Dentsply Sirona sees FY2021 EPS of $2.75-$2.90, versus the consensus of $2.87. Dentsply Sirona sees FY2021 revenue of $4.1-4.3 billion, versus the consensus of $4.25 billion.

For earnings history and earnings-related data on Dentsply Sirona (XRAY) click here.

You May Also Be Interested In

• Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
• Marathon Petroleum (MPC) PT Raised to $450 at UBS
• TD Cowen Reiterates Buy Rating on Boston Scientific (BSX)